Home/Healthcare/Medical Devices/Automated Sample Storage Systems Market

Automated Sample Storage Systems Market - Forecasts from 2026 to 2031

Detailed study of automated sample storage technologies, inventory tracking systems, and research infrastructure growth.

Market Size in 2026
USD 1.9 billion
Market Size in 2031
USD 3.3 billion
CAGR
11.7%
Study Period
2021-2031
$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

📞

Your data is secure. We do not share information with any third party.

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Report IDKSI061611951
PublishedApr 2026
Pages145
FormatPDF, Excel, PPT, Dashboard
Frequently Asked Questions

The Automated Sample Storage Systems market is forecast to reach USD 3.3 billion by 2031, growing significantly from USD 1.9 billion in 2026. This robust expansion represents a Compound Annual Growth Rate (CAGR) of 11.7%, driven by increasing demands for robust sample integrity in pharmaceutical research and large-scale biobanking.

Pharmaceutical and Biotechnology companies currently represent the largest end-user segment, leading the demand for automated sample storage systems. The high cost associated with drug failure necessitates the preservation of vast compound libraries, making these automated systems vital for ensuring the long-term viability and quality of critical research projects.

North America continues to dominate the Automated Sample Storage Systems market as the regional leader. This leadership is primarily attributed to an established concentration of global pharmaceutical R&D facilities within the region, alongside high capital availability that supports extensive laboratory infrastructure upgrades and adoption of advanced systems.

The market is undergoing a significant technology transition from standalone freezer units towards fully networked, 'Goods-to-Person' robotic systems that prioritize sample throughput. Modern systems are also engineered to minimize thermal cycling for delicate materials and improve sustainability through energy-efficient compression technology and optimized cooling profiles, reducing operational expenditures.

Regulatory influence from global health authorities like the FDA and EMA is a primary structural driver, demanding enhanced validation for specimen storage. Stricter Good Manufacturing Practice (GMP) guidelines require automated, tamper-proof audit trails for biological materials, enforcing a market-wide shift from manual documentation to digital, system-logged inventory management to ensure compliance and traceability.

While specific companies are not detailed, the report highlights that vendors are increasingly prioritizing sustainability by developing energy-efficient compression technology and optimized cooling profiles to lower operational expenditure. The market is also moving towards integrated workflows where storage systems directly interface with Laboratory Information Management Systems (LIMS), streamlining research processes.

Need data specifically for your business?Request Custom Research →
Related Reports

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon